Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-30 Purchase | 2026-05-01 4:39 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,706 | $2.69 | $4,589 | 16,229 (Indirect Direct) | View |
| 2026-04-30 Purchase | 2026-05-01 4:38 pm | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 2,190 | $2.69 | $5,891 | 6,498 (Direct) | View |
| 2026-04-30 Purchase | 2026-05-01 4:37 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 2,034 | $2.69 | $5,471 | 10,301 (Indirect Direct) | View |
| 2026-04-30 Purchase | 2026-05-01 4:36 pm | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,511 | $2.69 | $4,065 | 7,976 (Indirect Direct) | View |
| 2026-04-30 Purchase | 2026-05-01 4:35 pm | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,748 | $2.69 | $4,702 | 6,774 (Indirect Direct) | View |
| 2026-04-30 Purchase | 2026-05-01 4:34 pm | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 1,986 | $2.69 | $5,342 | 7,763 (Indirect Direct) | View |
| 2026-04-15 Purchase(A) | 2026-04-30 4:33 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 1,843 | $2.97 | $5,474 | 8,267 (Indirect Direct) | View |
| 2026-03-31 Purchase(A) | 2026-04-30 4:32 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 2,136 | $2.535 | $5,415 | 6,424 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:55 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,545 | $2.97 | $4,589 | 14,523 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:54 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 1,843 | $2.97 | $5,474 | 9,780 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:52 pm | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,369 | $2.97 | $4,066 | 6,465 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:51 pm | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,583 | $2.97 | $4,702 | 5,026 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:50 pm | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 1,799 | $2.97 | $5,343 | 5,777 (Indirect Direct) | View |
| 2026-04-15 Purchase | 2026-04-17 4:49 pm | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 1,984 | $2.97 | $5,892 | 4,308 (Direct) | View |
| 2026-03-31 Purchase | 2026-04-02 5:12 pm | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 789 | $2.535 | $2,000 | 818 (Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:20 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,810 | $2.535 | $4,588 | 12,978 (Indirect Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:18 pm | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 2,324 | $2.535 | $5,891 | 2,324 (Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:17 pm | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 2,072 | $2.535 | $5,253 | 2,188 (Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:15 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 2,136 | $2.535 | $5,415 | 7,937 (Indirect Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:11 pm | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,603 | $2.535 | $4,064 | 5,096 (Indirect Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:09 pm | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,854 | $2.535 | $4,700 | 3,443 (Indirect Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:08 pm | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 2,107 | $2.535 | $5,341 | 3,978 (Indirect Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 5:06 pm | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 2,269 | $2.535 | $5,752 | 2,325 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-01 Exercise | 2026-02-04 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 49 | $0 | 11,168 (Direct) | View |
| 2026-01-01 Exercise | 2026-02-04 5:07 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 193 | $0 | 3,493 (Direct) | View |
| 2026-01-01 Exercise | 2026-02-04 5:05 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 193 | $0 | 1,589 (Direct) | View |
| 2026-01-01 Exercise | 2026-02-04 5:04 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 249 | $0 | 1,871 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:41 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 400,000 | $0 | 400,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:39 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 400,000 | $0 | 400,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:36 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 400,000 | $0 | 400,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 400,000 | $0 | 400,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 272,000 | $0 | 272,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:29 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 384,000 | $0 | 384,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:27 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 432,000 | $0 | 432,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:25 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 444,000 | $0 | 444,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:23 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 1,024,000 | $0 | 1,024,000 (Direct) | View |